Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

BIOFLORIDA, INC.

Filed by BUCHANAN INGERSOLL & ROONEY PC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 20, 2026
Income
$20,000.00
Expenses
Not reported
Filing UUID
c59c373e-3d36-459f-afce-9cc49022f12a
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

CPT · Copyright/Patent/Trademark

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

HCR · Health Issues

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

MAN · Manufacturing

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

MED · Medical/Disease Research/Clinical Labs

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

MMM · Medicare/Medicaid

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

PHA · Pharmacy

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.